Shots: Verily has expedite the COVID-19 testing with a new lab-based at South San Francisco. The lab will use the technology from Thermo Fisher Scientific’s TaqPath test kit that has […]readmore
Tags : Focusing
Shots: Merck will acquire all outstanding shares of Themis in exchange for an undisclosed cash payment. The acquisition follows the ongoing collaboration between the two companies to develop vaccine candidates […]readmore
Shots: Vividion to receive $135M upfront in cash and is eligible to receive billion dollars preclinical, development and commercial milestones along with royalties on sales of commercialized products resulting from […]readmore
Shots: Ferring launches a new company FerGene focusing the global development and commercialization of Nadofaragene firadenovec in the US for the patients with Bacillus Calmette-Guérin (BCG) unresponsive, non-muscle invasive bladder […]readmore
Shots: The BMS-Pfizer Alliance and Fitbit collaborate to develop educational content and guidance, supporting patients with a high risk of AFib. The companies will focus on providing information to encourage […]readmore
Shots: ImaginAb signs a multi-year agreement with AstraZeneca, Pfizer & Takeda for the development of ImaginAb’s CD8 ImmunoPET technology. The global companies will get early access to clinical and imaging […]readmore
Shots: Innovate to acquire all outstanding shares of RDD in exchange for a combination of common and preferred shares and create a new Nasdaq listed company. Following the closing of […]readmore
Shots: Sanofi and Regeneron collaborate with National Eczema Association for launching the next phase Understand AD, an educational campaign focusing on educating about moderate-to-severe atopic dermatitis The Understand AD team […]readmore